동운아나텍

094170KOSDAQ

53.3 / 100

Reference Date: 2026-09-08

Financial Score12.0 / 40

News Sentiment21.3 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Declined 12.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Dongun Anatech is a system semiconductor company specializing in e-OIS and OIS ICs for smartphone cameras, as well as HAPTIC, LIDAR, and ADAS control ICs for automotive applications. Operating as a fabless semiconductor firm, it designs and sells ICs, supplying them to global smartphone manufacturers and automotive suppliers. The company is also expanding into new digital healthcare ventures, such as saliva-based glucose monitoring systems.

Number of Employees

203people

Average Salary

94.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

525.96Industry Average 15.000.0Point

35.1x industry avg (risky)

PBR

8.26Industry Average 1.200.0Point

6.9x industry avg (risky)

ROE

1.45Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

34.29Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20254.5 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲8.2% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼58.3% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 34.3% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 5Neutral 0Negative 0Average Sentiment Score 85

Positive
[인터뷰] 데이비드 웡 "D-SaLife, CGM형 기술 80% 수준"
동운아나텍과의 협업이 예상보다 빠르게 진행되어 기술 수준이 기대를 초과하고 있음을 데이비드 웡 UCLA 교수가 강조했습니다.
Positive
"기대 이상의 결과" 디썰라이프 임상한 美 '타액 전문가' 상용화 낙관
동운아나텍의 디썰라이프 임상 결과가 예상을 뛰어넘어 긍정적인 전망을 제공함.
Positive
'타액으로 혈당 측정' 디썰라이프, 美 UCLA 파일럿 임상서 성능 입...
동운아나텍 관련 연구가 UCLA와의 협업을 통해 혈당 측정 정확도 향상을 입증, 긍정적 시장 반응 예상.

Detailed Momentum

52-week position3.0Point

52w lower range (28%)

Current 27,350Won52-week high 55,10052-week low 16,280

1-month return1.0Point

1m -12.76% (falling)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-24
Neutral반기보고서 (2026.06)2026-08-14